Written by Paula P.
Media can only be downloaded from the desktop version of this website. Share Leave a comment Neurotechnology, a rapidly growing field that draws upon biology, medical imaging, computer science and other areas of research, is providing a fertile ground for both existing businesses and startups.
With the aim of grooming the sector's future leaders, MIT has created a new research program and is offering numerous classes — including one on how to launch businesses in the industry.
That program, says its director Charles Jennings, was created to take advantage of the fact that "MIT is almost in a uniquely good position to develop new technologies" in this field, thanks to its confluence of expertise in neurosciences, engineering and computation.
Because of its inherently cross-disciplinary nature, MIT's work in neurotechnology spans many labs and departments. Business-minded The new classes helping to put MIT at the forefront of this field include "Principles of Neuroengineering," "Applications of Neuroengineering," and "Neurotechnology Ventures," which were spawned by student-led seminars on the subject that were taught in the late s.
The series of three courses was supported by the largest-ever grant in the history of MIT alumni class funds. In "Neurotechnology Ventures," which was taught in the Spring and Fall semesters, representatives of a variety of neurotech companies presented stories of how their technical innovations came about and were developed or are now developing into functioning businesses.
Then, students formed teams to produce business plans for new neurotech ventures of their own. In this climate, which has been compared to the biotechnology boom of the s, MIT's class seeks to give its students guidance in how to turn their new ideas and insights into profitable companies.
The guest speakers in each class described the details of their ventures to offer students a clear sense of the nitty-gritty of turning ideas into practice.
Each class was co-taught via teleconferencing with the University of Hong Kong, where Ellis-Behnke is based, and China Medical University Hospital in Taiwan, and the hope is that it will grow to other locations.
For a spinal cord trial, it may take six years to get patients in a clinical trial in the U. In Asia we can get patients into a clinical trial in six months. If a dozen or so students develop new plans each time the class is given, "after a decade, these could be the people shaping the field.
And that's one of the reasons he chose to come to MIT in the first place, and to teach this class here: Thanks to that approach, MIT may be well positioned to nurture the future leaders of this field. Where better than MIT to come up with the next generation of systems?Nice NYTimes piece by Michael Kimmelman on the Madrid Río-- In Madrid’s Heart, Park Blooms Where a Freeway Once Blighted "More than six miles long, it transforms a formerly neglected area in the middle of Spain’s capital.
Its creation, in four years, atop a complex network of tunnels dug to bury an intrusive highway, also rejuvenates a long .
Find helpful customer reviews and review ratings for Acid Reflux Diet: Best Foods To Treat & Cure GERD at initiativeblog.com Read . What's the impact of epilepsy? Can having seizures make me more likely to develop other problems?
Epilepsy Foundation Efforts to Reduce the Impact of Epilepsy-Related Comorbidities: We Can’t Wait ; The Epilepsy Pipeline Conference: Accelerating Hope. NeuroInsights Reveals Brain Industry's Investment Opportunities, Risks and Competitive Landscape in New Industry-Defining Report.
San Francisco, Boston, San Diego, and London Lead Global 'Brain Industry' Development, New NeuroInsights Study Shows; First Study of Neurotechnology. Neurotech Inc was founded in Neurotech Inc specializes in Business Services At Non-commercial Site. Neurotech Inc has 1 employees and estimated revenues of $61,